Gemini Space Station, Inc. Class A Common Stock (GEMI)

This page provides a detailed financial overview of Gemini Space Station, Inc. (GEMI), focusing on its revenue breakdown, alongside other financial data like insider trading, institutional holdings, corporate lobbying, and analyst ratings. It also includes information about the company's business model as a bridge between traditional finance and the crypto economy.

Faruqi & Faruqi, LLP has reminded investors of Gemini Space Station (GEMI) about the May 18, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges that Gemini and its executives made false and misleading statements regarding the viability of its core crypto platform business, international expansion, and post-IPO financial prospects, leading to an expensive restructuring. This reminder follows significant stock price drops after announcements of a corporate pivot, workforce reduction, exit from international markets, and the departure of key executives.

Gemini Space Station's interim CFO, Danijela Stojanovic, sold 7,940 Class A common stock shares at a weighted average price of $4.05 on August 20, 2026. This transaction was not discretionary but rather to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs), as per the company's Automatic Sell-to-Cover Policy. Following the sale, Stojanovic directly held 187,923 shares of GEMI.

Analysts have revised down their revenue forecasts and increased their loss per share expectations for Gemini Space Station, Inc. (GEMI) following its latest quarterly results. The company's shares fell 4.6% after reporting revenues of US$45m, which beat expectations, but also a 26% increase in statutory losses per share. The consensus price target for GEMI has also decreased by 6.1% to US$5.94, reflecting concerns about the weaker outlook compared to the broader industry.

Gemini Space Station reported a 37% year-over-year revenue growth to $45.5 million in Q2 2026, primarily driven by services and OTC business, despite a 38% decline in exchange revenue. The company launched commission-free U.S. stock trading and expanded its derivatives clearinghouse, emphasizing a "super app" strategy with a broader product portfolio. Despite a net loss of $107.7 million, operating loss improved sequentially due to significant cost restructuring, including a 40% reduction in headcount from its Q3 2025 peak, and the company views prediction markets as a key near-term growth opportunity.